Gets FDA Clearance

Related by string. * get . gets . GETS . Geter . geting : GET KNOBIAS IN REAL . E LOAN Get . GET YOUR SYS CON . debut Get Lifted / FDAs . fda . Fda : Drug Administration FDA . FDA Orphan Drug . FDA MedWatch Adverse Event . reformulates existing FDA / Clearances . CLEARANCE . clearances . clearance : Receives FDA Clearance . slum clearance . calculated creatinine clearance . antitrust clearance * *

Related by context. Frequent words. (Click for all words.) 86 FDA Clears 85 Receives FDA Clearance 80 Completes Enrollment 77 Presents Positive 76 FDA Accepts 76 FDA Clearance 76 Drug Candidate 75 Patient Enrollment 75 Receives Patent 75 Significantly Reduces 75 Q1 Loss Narrows 75 Introduces Next Generation 74 Awarded Patent 74 Q2 Loss Narrows 74 Q3 Loss Narrows 74 Clinical Trial Results 73 Reduces Risk 73 Study Demonstrates 73 Inc Therapeutic Competitors 73 Receives CE 73 Achieves Milestone 73 FDA Approves 73 Completes Tender Offer 72 Q4 Loss Narrows 72 k Clearance 72 Regains Compliance 72 Develop Next Generation 72 Q3 Loss Widens 72 Q4 Loss Widens 72 Equipment Deals 72 Q2 Loss Widens 72 Signs Licensing Agreement 72 Provides Guidance 72 Announces Initiation 71 Launches Next Generation 71 Begins Shipping 71 Files Patent 71 Generic Version 71 Provides Comprehensive 71 Shows Promise 71 Non Invasive 71 Preclinical Data 70 Phase III Clinical Trial 70 Q1 Loss Widens 70 Updates Guidance 70 Phase III Trial 70 Pivotal Trial 70 Unveils Next Generation 70 Announces Presentation 70 Acquires Exclusive 69 Heart Failure Patients 69 Announces Enhancements 69 Low Dose 69 Receives Positive 69 Introduces Innovative 69 Unveils Innovative 69 Announce Collaboration 69 Finalizes Acquisition 69 Report companiesandmarkets.com adds 69 Provide Comprehensive 69 Posts Wider Loss 69 Receives Regulatory 69 Announces Publication 69 Guides FY# Quick Facts 69 Provides Preliminary 69 Net Loss Narrows 69 Forecast Quick Facts 69 Q4 Profit Surges 69 Cholesterol Drug 69 Pivotal Phase III 68 Reports Positive 68 Unveils Latest 68 Extends Tender Offer 68 Lowers Guidance 68 Announces Successful Completion 68 Initiates Phase 68 Benign Prostatic Hyperplasia 68 FDA Warns 68 J Am Coll 68 Guides FY# 68 Acquire Assets 68 Issues Guidance 68 Patent Lawsuit 68 COMUNICADO 68 Small Molecule 68 Signs Agreements 68 Hold Fourth Quarter 68 Guides Q4 68 Protects Against 68 Overactive Bladder 68 Guides Q2 67 Discontinues 67 Patients Treated 67 Reaffirms Guidance 67 Bullish Engulfing Pattern 67 Announces Issuance 67 Revenues Decline 67 Extends Leadership 67 Expand Relationship 67 Announces Organizational Changes 67 Strengthens Its

Back to home page